BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang C, Ma K, Li WY. IL-6 Promotes Cancer Stemness and Oncogenicity in U2OS and MG-63 Osteosarcoma Cells by Upregulating the OPN-STAT3 Pathway. J Cancer 2019;10:6511-25. [PMID: 31777581 DOI: 10.7150/jca.29931] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Menéndez ST, Gallego B, Murillo D, Rodríguez A, Rodríguez R. Cancer Stem Cells as a Source of Drug Resistance in Bone Sarcomas. J Clin Med 2021;10:2621. [PMID: 34198693 DOI: 10.3390/jcm10122621] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Peng C, Yu C, Huang C, Liao Y, Hsieh P, Chu P, Yu C, Lin S. Magnolol inhibits cancer stemness and IL-6/Stat3 signaling in oral carcinomas. Journal of the Formosan Medical Association 2021. [DOI: 10.1016/j.jfma.2021.01.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Karavyraki M, Porter RK. Evidence of a role for interleukin-6 in anoikis resistance in oral squamous cell carcinoma. Med Oncol 2022;39:60. [PMID: 35484352 DOI: 10.1007/s12032-022-01664-5] [Reference Citation Analysis]
4 Shi L, Hou J, Wang L, Fu H, Zhang Y, Song Y, Wang X. Regulatory roles of osteopontin in human lung cancer cell epithelial-to-mesenchymal transitions and responses. Clin Transl Med 2021;11:e486. [PMID: 34323425 DOI: 10.1002/ctm2.486] [Reference Citation Analysis]
5 Zhang H, Song J. Knockdown of lncRNA C5orf66-AS1 inhibits osteosarcoma cell proliferation and invasion via miR-149-5p upregulation. Oncol Lett 2021;22:757. [PMID: 34539861 DOI: 10.3892/ol.2021.13018] [Reference Citation Analysis]
6 Lu M, Xie K, Lu X, Lu L, Shi Y, Tang Y. Notoginsenoside R1 counteracts mesenchymal stem cell-evoked oncogenesis and doxorubicin resistance in osteosarcoma cells by blocking IL-6 secretion-induced JAK2/STAT3 signaling. Invest New Drugs 2021;39:416-25. [PMID: 33128383 DOI: 10.1007/s10637-020-01027-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ashrafizadeh M, Delfi M, Hashemi F, Zabolian A, Saleki H, Bagherian M, Azami N, Farahani MV, Sharifzadeh SO, Hamzehlou S, Hushmandi K, Makvandi P, Zarrabi A, Hamblin MR, Varma RS. Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy. Carbohydr Polym 2021;260:117809. [PMID: 33712155 DOI: 10.1016/j.carbpol.2021.117809] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
8 Shu X, Liu W, Liu H, Qi H, Wu C, Ran YL. Analysis of microRNA expression in CD133 positive cancer stem‑like cells of human osteosarcoma cell line MG-63. PeerJ 2021;9:e12115. [PMID: 34557357 DOI: 10.7717/peerj.12115] [Reference Citation Analysis]
9 Armartmuntree N, Jusakul A, Sakonsinsiri C, Loilome W, Pinlaor S, Ungarreevittaya P, Yong CH, Techasen A, Imtawil K, Kraiklang R, Suwannakul N, Kaewlert W, Chaiprasert T, Thanan R, Murata M. Promoter hypermethylation of early B cell factor 1 (EBF1) is associated with cholangiocarcinoma progression. J Cancer 2021;12:2673-86. [PMID: 33854627 DOI: 10.7150/jca.52378] [Reference Citation Analysis]
10 Nemcakova I, Jirka I, Doubkova M, Bacakova L. Heat treatment dependent cytotoxicity of silicalite-1 films deposited on Ti-6Al-4V alloy evaluated by bone-derived cells. Sci Rep 2020;10:9456. [PMID: 32528137 DOI: 10.1038/s41598-020-66228-x] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Peng D, Lin B, Xie M, Zhang P, Guo Q, Li Q, Gu Q, Yang S, Sen L. Histone demethylase KDM5A promotes tumorigenesis of osteosarcoma tumor. Cell Death Discov 2021;7:9. [PMID: 33436536 DOI: 10.1038/s41420-020-00396-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Aramini B, Masciale V, Grisendi G, Banchelli F, D'Amico R, Maiorana A, Morandi U, Dominici M, Haider KH. Cancer stem cells and macrophages: molecular connections and future perspectives against cancer. Oncotarget 2021;12:230-50. [PMID: 33613850 DOI: 10.18632/oncotarget.27870] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Bassi G, Panseri S, Dozio SM, Sandri M, Campodoni E, Dapporto M, Sprio S, Tampieri A, Montesi M. Scaffold-based 3D cellular models mimicking the heterogeneity of osteosarcoma stem cell niche. Sci Rep 2020;10:22294. [PMID: 33339857 DOI: 10.1038/s41598-020-79448-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
14 Rothzerg E, Ho XD, Xu J, Wood D, Märtson A, Maasalu K, Kõks S. Alternative splicing of leptin receptor overlapping transcript in osteosarcoma. Exp Biol Med (Maywood) 2020;245:1437-43. [PMID: 32787464 DOI: 10.1177/1535370220949139] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Wu W, Yang H, Wang Z, Zhang Z, Lu X, Yang W, Xu X, Jiang Y, Li Y, Fan X, Shao Q. A Noncanonical Hedgehog Signaling Exerts a Tumor-Promoting Effect on Pancreatic Cancer Cells Via Induction of Osteopontin Expression. Cancer Biother Radiopharm 2021. [PMID: 34978897 DOI: 10.1089/cbr.2021.0317] [Reference Citation Analysis]
16 Hu Y, Luo X, Zhou J, Chen S, Gong M, Deng Y, Zhang H. Piperlongumine inhibits the progression of osteosarcoma by downregulating the SOCS3/JAK2/STAT3 pathway via miR-30d-5p. Life Sci 2021;277:119501. [PMID: 33862108 DOI: 10.1016/j.lfs.2021.119501] [Reference Citation Analysis]
17 Mirzaei S, Gholami MH, Mahabady MK, Nabavi N, Zabolian A, Banihashemi SM, Haddadi A, Entezari M, Hushmandi K, Makvandi P, Samarghandian S, Zarrabi A, Ashrafizadeh M, Khan H. Pre-clinical investigation of STAT3 pathway in bladder cancer: Paving the way for clinical translation. Biomed Pharmacother 2021;133:111077. [PMID: 33378975 DOI: 10.1016/j.biopha.2020.111077] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
18 Hsu PC, Chen YH, Cheng CF, Kuo CY, Sytwu HK. Interleukin-6 and Interleukin-8 Regulate STAT3 Activation Migration/Invasion and EMT in Chrysophanol-Treated Oral Cancer Cell Lines. Life (Basel) 2021;11:423. [PMID: 34063134 DOI: 10.3390/life11050423] [Reference Citation Analysis]
19 Allende C, Higgins B, Johns J. Comparison of serum cytokine concentrations between healthy dogs and canine osteosarcoma patients at the time of diagnosis. Vet Immunol Immunopathol 2020;227:110084. [PMID: 32559421 DOI: 10.1016/j.vetimm.2020.110084] [Reference Citation Analysis]
20 Butti R, Kumar TVS, Nimma R, Banerjee P, Kundu IG, Kundu GC. Osteopontin Signaling in Shaping Tumor Microenvironment Conducive to Malignant Progression. Adv Exp Med Biol 2021;1329:419-41. [PMID: 34664250 DOI: 10.1007/978-3-030-73119-9_20] [Reference Citation Analysis]
21 Sun Q, Shang Y, Sun F, Dong X, Niu J, Li F. Interleukin-6 Promotes Epithelial-Mesenchymal Transition and Cell Invasion through Integrin β6 Upregulation in Colorectal Cancer. Oxid Med Cell Longev 2020;2020:8032187. [PMID: 32855767 DOI: 10.1155/2020/8032187] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
22 Wang H, Li J, Xu W, Li C, Wu K, Chen G, Cui J. The mechanism underlying arsenic-induced PD-L1 upregulation in transformed BEAS-2B cells. Toxicol Appl Pharmacol 2021;435:115845. [PMID: 34953898 DOI: 10.1016/j.taap.2021.115845] [Reference Citation Analysis]